Synthetic biopolymers are effective cues to replace damaged tissue in the tissue
engineering (TE) field, both for in vitro and in vivo application. Among them, poly-l-lactic acid …

Over the last decades, the fabrication of 3D tissues has become commonplace in tissue
engineering and regenerative medicine. However, conventional 3D biofabrication …

Transplantation of synovial fluid-derived mesenchymal stem cells (SF-MSCs) is a viable
therapy for cartilage degeneration of osteoarthritis (OA). But controlling chondrogenic …

Alginate biopolymers are characterized by favorable properties, of biocompatibility,
degradability, and non-toxicity. However, the poor stability properties of alginate have limited …

Kidney disease can be either acute kidney injury (AKI) or chronic kidney disease (CKD) and
it can lead to the development of functional organ failure. Mesenchymal stem cells (MSCs) …

Stroke, a global disease with a high disability rate, has limited options for functional
rehabilitation and results in an adverse impact on patients' lives. In recent years …

The articular cartilage disorder at the junction mainly results from constantly repeated
dynamic tension/compression effects with ageing and lack of intrinsic defect repairability …

Stroke, the most prevalent cerebrovascular disease, causes serious loss of neurological
function and is the leading cause of morbidity and mortality worldwide. Despite advances in …

Neurodegenerative disease is a kind of chronic, progressive nervous system disease
characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the …

The dedifferentiation of chondrocytes in cartilage tissue engineering (CTE) remains an
unsolved challenge for the successful repair of severe articular cartilage defects. We …